Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trialḰazunori Toyoda, Naoko Kumagai, Takenori Yamaguchi et al.|The Lancet Neurology|2019Cited by 216
Feasibility and Efficiency of Human Bone Marrow Stromal Cell Culture with Allogeneic Platelet Lysate‐Supplementation for Cell Therapy against StrokeChengbo Tan, Kiyohiro Houkin|Stem Cells International|2016Cited by 22